Mineralys Therapeutics
MLYS
22.09
+0.14
+0.64%
Mineralys Therapeutics
US · MLYS
#2760 by market cap
Listed 2023
22.09
+0.14
+0.64%
Live - 5344 symbols - heartbeat 475s ago
· 2026-10-08 07:31
Pre-market
21.91
-0.81%
After-hours
22.38
+1.31%
Overnight
22.50
+1.86%
- Market cap
- 1.95B
- P/E (TTM)i
- -5.26
- P/Bi
- 3.54
- EPSi
- -2.29
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on MLYS?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 6 years
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 532.00K | 2.42M | 5.23M | 14.30M | 23.82M | 38.60M |
| Research & development | 2.41M | 16.31M | 26.25M | 70.36M | 168.58M | 132.01M |
| Operating profit | -2.94M | -18.73M | -31.48M | -84.66M | -192.40M | -170.60M |
| Pretax profit | -3.43M | -19.41M | -29.80M | -71.90M | -177.81M | -154.65M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -3.43M | -19.41M | -29.80M | -71.90M | -177.81M | -154.65M |
| Basic EPS | 0 | -4 | -1 | -2 | -4 | -2 |
| Diluted EPS | -0.35 | -3.77 | -0.76 | -1.99 | -3.66 | -2.29 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 6.57M | 8.47M | 9.68M | 13.88M | 20.98M | 24.66M |
| Research & development | 37.88M | 38.28M | 31.45M | 24.40M | 24.37M | 221.38M |
| Operating profit | -44.45M | -46.75M | -41.13M | -38.28M | -45.34M | -246.04M |
| Pretax profit | -42.21M | -43.27M | -36.93M | -32.23M | -39.34M | -241.07M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -42.21M | -43.27M | -36.93M | -32.23M | -39.34M | -241.07M |
| Basic EPS | -1 | -1 | -1 | 0 | 0 | -3 |
| Diluted EPS | -0.79 | -0.66 | -0.52 | -0.40 | -0.47 | -2.85 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | 1.47M | 11.12M | 112.81M | 249.10M | 205.35M | 661.39M |
| Cash & ST investments | 1.41M | 10.61M | 110.11M | 236.57M | 198.19M | 656.64M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.49M | 11.13M | 114.44M | 251.64M | 205.90M | 661.81M |
| Total current liabilities | 5.08M | 5.05M | 8.07M | 10.48M | 14.65M | 15.11M |
| Short-term debt | 4.50M | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 5,083,000.00 | 34,050,000.00 | 166,711,000.00 | 10,482,000.00 | 14,646,000.00 | 15,113,000.00 |
| Total equity | -3.60M | -22.93M | -52.27M | 241.15M | 191.26M | 646.69M |
| Retained earnings | -3.60M | -23.01M | -52.81M | -124.71M | -302.52M | -457.17M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 354.51M | 335.27M | 599.80M | 661.39M | 652.47M | 665.80M |
| Cash & ST investments | 343.03M | 324.92M | 593.63M | 656.64M | 646.06M | 661.41M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 354.94M | 335.72M | 599.95M | 661.81M | 652.86M | 667.85M |
| Total current liabilities | 13.39M | 22.17M | 23.52M | 15.11M | 14.72M | 19.32M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 13,386,000.00 | 22,173,000.00 | 23,520,000.00 | 15,113,000.00 | 14,718,000.00 | 116,936,000.00 |
| Total equity | 341.56M | 313.55M | 576.43M | 646.69M | 638.14M | 550.92M |
| Retained earnings | -344.73M | -388.00M | -424.94M | -457.17M | -496.51M | -737.58M |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.46M | -14.56M | -29.22M | -81.17M | -166.31M | -142.42M |
| Depreciation & amortization | -- | -- | -- | 0 | 43.00K | 59.00K |
| Free cash flow | -2.46M | -14.56M | -29.22M | -81.17M | -166.41M | -142.43M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -1.63M | 202.99M | 116.06M | 578.36M |
| Ending cash balance | 1.41M | 10.66M | 87.70M | 49.30M | 114.09M | 172.92M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -45.49M | -30.17M | -28.87M | -37.89M | -39.47M | -32.56M |
| Depreciation & amortization | 15.00K | 16.00K | 15.00K | 13.00K | 6.00K | 5.00K |
| Free cash flow | -45.49M | -30.17M | -28.87M | -37.90M | -39.47M | -32.56M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 189.17M | 8.66M | 288.59M | 91.95M | 20.22M | 143.90M |
| Ending cash balance | 165.01M | 101.79M | 217.60M | 172.92M | 112.78M | 138.27M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -76.13 | -82.24 | -36.91 |
| ROA %i | -230.55 | -296.95 | -47.46 | -39.28 | -77.72 | -35.65 |
| ROIC %i | -- | -- | -- | -89.64 | -88.99 | -40.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.29 | 2.20 | 13.98 | 23.76 | 14.02 | 43.76 |
| Quick ratioi | 0.28 | 2.10 | 13.65 | 22.57 | 13.53 | 43.45 |
| Debt / assetsi | 302.83 | -- | -- | -- | -- | -- |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -28.79 | -717.81 | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -56.31 | -63.21 | -42.14 | -36.91 | -30.98 | -80.88 |
| ROA %i | -53.69 | -58.32 | -39.48 | -35.65 | -30.12 | -69.67 |
| ROIC %i | -60.18 | -67.28 | -45.26 | -40.72 | -35.01 | -85.78 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 26.48 | 15.12 | 25.50 | 43.76 | 44.33 | 34.46 |
| Quick ratioi | 25.63 | 14.65 | 25.24 | 43.45 | 43.90 | 34.24 |
| Debt / assetsi | -- | -- | -- | -- | -- | -- |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 07:31:59 · For reference only, not investment advice and not tailored to your situation.